Role of myo-inositol in polycystic ovary syndrome
Introduction Polycystic ovary syndrome (PCOS) is a chronic and multisystemic metabolic-endocrine disorder that affects reproductive health and increases the risk of female neoplasms. Classically, PCOS is characterized by clinical and/or biochemical hyperandrogenism and anovulation [1]. Its estimated prevalence is highly variable and ranges between 4.5 and 11.2% in adult women, based on different series [1]. […]